FIELD: medicine, oncology.
SUBSTANCE: one should evaluate morphological parameters of tumor, moreover, the degree of tumor differentiation should be evaluated in points (X1): low degree of differentiation - 1 point; moderate - 2 points; high - 3 points. The nuclear area of cancer cell in sq. mcm (X2) should be measured with ocular-micrometer or analyzer of TV representation. Mitotic index (%0) (X3) should be determined due to calculating total quantity of division figures/1000 tumor cells. Specific portion of "lethal" mitotic forms against total quantity (%) (X4), the quantity of free cells/10000 mcm stromal area (X5), the density of vascularization (sq. mcm)/1000sq. mcm stromal area (X6) should be determined with analyzer of TV representation. The terms for the onset of relapse (Y) in mo should be determined according to the following formula: Y(mo)=(-30.42)-12,31*x1+0.04*x2-1.61*x3+1.41*x4+1.13*x5+1.29*x6. The present diagnostics enables to increase accuracy in detecting the duration of relapse-free period according to morphological characteristics of primary tumor.
EFFECT: higher accuracy.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING LIFE DURATION IN PATIENTS WITH SEROUS RELAPSING OVARIAN CARCINOMA | 2005 |
|
RU2297788C1 |
METHOD FOR PREDICTION OF RISK OF TUMOUR PROGRESSION IN PATIENTS WITH OVARIAN CANCER | 2023 |
|
RU2816339C1 |
METHOD OF ESTIMATION OF RISK OF RECURRENCY OF OVARIAN CANCER | 2017 |
|
RU2658047C1 |
METHOD FOR PREDICTING SURVIVAL PERIOD IN SEROUS OVARY CARCINOMA PATIENTS OF REPRODUCTIVE AGE | 2005 |
|
RU2290640C1 |
METHOD FOR PREDICTING THE RELAPSE OF SEROUS OVARIAN CANCER | 2005 |
|
RU2290078C1 |
METHOD FOR PREDICTING LIFE DURATION OF PATIENTS SUFFERING FROM CHOLANGIOGENIC HEPATIC CARCINOMA | 2001 |
|
RU2202957C1 |
METHOD FOR PREDICTING SEROUS OVARIAN CARCINOMA PATIENTS SURVIVAL PERIOD IN CLIMACTERIC PERIOD AND POSTMENOPAUSE | 2005 |
|
RU2291435C1 |
LIFE SPAN PREDICTION METHOD FOR PATIENTS SUFFERING FROM MUCINOUS OVARIAN CARCINOMA | 2008 |
|
RU2354303C1 |
PREDICTION METHOD OF LIFE DURATION IN PATIENTS WITH MESONEPHROID OVARIAN CARCINOMA | 2008 |
|
RU2357672C1 |
METHOD FOR PREDICTION OF PROBABILITY OF POSSIBLE EXECUTION OF OPTIMUM CYTOREDUCTIVE OPERATION IN PATIENTS WITH DISSEMINATED FORMS OF OVARIAN CANCER | 2017 |
|
RU2637399C1 |
Authors
Dates
2007-05-20—Published
2005-10-05—Filed